Ipamorelin is a synthetic pentapeptide research compound studied for its interaction with growth hormone secretagogue receptor pathways and endocrine signaling.

Laboratory and preclinical research involving Ipamorelin has examined growth hormone secretagogue receptor activity, pituitary signaling, growth-hormone-axis biology, peptide–receptor interactions, and neuroendocrine regulatory pathways. Early pharmacological studies characterized Ipamorelin as a selective growth hormone secretagogue and investigated how its signaling profile differs from other growth hormone-releasing peptides.

Ipamorelin remains an experimental research compound for investigating growth hormone secretagogue signaling, pituitary biology, endocrine regulation, and peptide receptor pharmacology.